期刊文献+

白细胞介素-17A在宫颈癌中的表达及其与肿瘤血管生成之间的关系 被引量:3

Expression of IL-17A in Cervical Carcinoma and Its Relationship with Tumor Angiogenesis
原文传递
导出
摘要 目的:探讨白细胞介素(IL)-17A在宫颈癌中的表达以及IL-17A与肿瘤血管生成之间的关系。方法:分别收集80例手术切除的宫颈癌组织及其癌旁正常宫颈组织。使用免疫组化方法检测IL-17A和CD31的表达情况。观察IL-17A在宫颈癌组织中的表达以及与肿瘤临床病理特点的相关性;计算微血管密度(MVD),评价IL-17A表达与宫颈癌肿瘤血管生成的关系。结果:IL-17A在宫颈癌组织表达量显著高于癌旁组织(P<0.01),其染色部位主要分布于胞质内;IL-17A的表达与宫颈癌的年龄、组织病理分级、临床分期、淋巴结转移之间并无相关性;CD31在宫颈癌组织表达量显著高于癌旁组织(P<0.05),IL-17A阳性的宫颈癌组织中MVD明显高于IL-17A阴性宫颈癌组织(P<0.01)。结论:IL-17A在宫颈癌组织高表达,可能与宫颈癌血管生成相关,而与宫颈癌患者的年龄、病理分级、临床分期、淋巴结转移无相关性。 Objective:To investigate the expression of IL-17A in cervical cancer and the relationship between IL-17A and tumor angiogenesis.Methods:Eighty samples cases of cervical cancer tissue and its adjacent normal cervical tissues were collected,immunohistochemistry was used to detect the expression of IL-17A and CD31.The correlation of expression of IL-17A in cervical cancer tissues with the clinicopathological features of the tumors were observed.Then,microvessel density(MVD)was calculated,and the relationship between IL-17A expression and angiogenesis in cervical cancer was evaluated.Results:The expression of IL-17A in cervical cancer tissues was significantly higher than that in adjacent tissues(P<0.01);the staining sites were mainly located in the cytoplasm;the expression of IL-17A had no relation to the age,histopathological grade,clinical stage and lymph node metastasis of cervical cancer;the expression of CD31 in cervical cancer was also significantly higher than that in adjacent tissues(P<0.05).In addition,the MVD in IL-17A -positive cervical cancer was significantly higher than that in IL-17A -negative cervical cancer(P<0.01).Conclusion:The high expression of IL-17A may be related to angiogenesis incervical cancer,but not to the age,pathological grade,clinical stage,and lymph node metastasis.
作者 陈宏
出处 《武汉大学学报(医学版)》 CAS 2018年第6期930-934,共5页 Medical Journal of Wuhan University
关键词 宫颈癌 IL-17A 肿瘤血管生成 Cervical Cancer IL-17A Tumor Angiogenesis
  • 相关文献

参考文献1

二级参考文献17

  • 1Piver MS, Rutledge F, Smith JP.Five classes of extened hysterectomy[J]. Obstet Gynecol, 1974, 44(2): 265-9.
  • 2Ito T, Ishizuka T, Suzuki K, et al. Cervical cancer in young Japanese women[J].Arch Gynecol Obstet, 2000, 264(1): 68-70.
  • 3Clark MA, Naahas W, Marker RJ, et al. Cervical cancer: women aged 35 and youngercompared to women aged 36 and older [J].Am J Clin Oncol, 1991, 14(2): 352-6.
  • 4Cuzick J, Sasieni P, Singer A. Risk factors for cervix cancer in young women[J].Eur J Cancer, 1996, 32A(3): 836-41.
  • 5Creasman WT, Zaino RJ, Major FJ, et al. Early invasive carcinoma of the cervix (3to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study [J]. AmJ Obstet Gynecol,1998, 178(1): 62-5.
  • 6Dargent D, Martin X, Sacchetoni A, et al. Laparoscopic vaginal radicaltrachelectomy: a treatment to preserve the fertility of cervical carcinoma patients[J].Cancer, 2000, 88(4): 1877-82.
  • 7Schlaerth JB, Spirtos NM, Schlaerth AC. Radical trachelectomy and pelviclymphadenectomy with uterine preservation in the treatment of cervical cancer[J]. Am JObstet Gynecol, 2003, 88(1): 29-32.
  • 8Lee CL, Huang KG, Wang CJ, et al. Laparoscopic radical trachelectomy for stage Ⅰbl cervical cancer [J]. J Am Assoc Gynecol Laparosc, 2003, 10(1): 111-5.
  • 9Yamamoto R, Okamoto K, Yukiharu T, et al. A study of risk factors for ovarianmetastases in stage Ⅰ b- Ⅲ b cervical carcinoma and analysis of ovarian function aftera transposition [J]. Gynecology,2001, 82(3): 312-6.
  • 10Olejek A, Wala D, Chimiczewski P, et al. Hormonal activity of transposed ovariesin young women treated for cervical cancer [J].Gynecol Endocrinol, 2001, 15(1): 5-13.

共引文献26

同被引文献24

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部